Transmissible spongiform encephalophaties: Transmission, mechanism of disease, and persistence

Current Opinion in Microbiology

Volumn 1, Issue 4, 1998, Pages 442-447

  Foster, James ^a   Hunter, Nora ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BIOLOGICAL MODEL; BOVINE SPONGIFORM ENCEPHALOPATHY; CATTLE; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; HUMAN; METABOLISM; PRION; PRION DISEASE; REVIEW; SCRAPIE; SHEEP;

ANIMALS; CATTLE; CREUTZFELDT-JAKOB SYNDROME; ENCEPHALOPATHY, BOVINE SPONGIFORM; HUMANS; MODELS, BIOLOGICAL; PRION DISEASES; PRIONS; SCRAPIE; SHEEP;

EID: 0032129737     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(98)80063-5     Document Type: Article

References (52)

1. Moore R, Melton D: Transgenic analysis of prion diseases. Molecular Human Reproduction 1997, 3:529-544.
2. Taylor DM, Woodgate SL, Fleetwood AJ, Cawthorne RJG: Effect of rendering procedures on the scrapie agent Vet Rec 1997, 141:643-649.
3. Cutlip RC, Miller JM, Lehmkuhl HD: Second passage of a US scrapie agent in cattle. J Comp Pathol 1997, 117:271-275.
4. Wilesmith JW, Wells GAH, Ryan JBM, Gavier-Widen D, Simmons MM: A cohort study to examine maternally-associated risk factors for bovine spongiform encephalopathy. Vet Rec 1997, 141:238-243.
5. Ferguson NM, Donnelly CA, Woolhouse MEJ, Anderson RM: A genetic interpretation of heightened risk of BSE in offspring of affected dams. Proc R Soc Lond Biol Sci 1997, 264:1445-1455.
6. Ironside JW, Bell JE: Florid plaques and new variant Creutzfeldt-Jacob disease. Lancet 1997, 350:1475.
7. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C et al.: Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997, 389:498-501. This study provides the first real evidence that the BSE agent causes both BSE and 'new variant' (v) CJD. It does this by identifying the BSE 'signature' of incubation periods and pathology in mice after transmission from brain of a case of vCJD, but not after the transmission of other types of CJD.
8. Hill AF, Desbruslais M, Joiner S, Sidle KCL, Gowland I, Collinge J: The same prion strain causes vCJD and BSE. Nature 1997, 389:448-450.
9. Raymond GJ, Hope J, Kocisko DA, Priola SA, Raymond LD, Bossers A, Ironside J, Will RG, Chen SG, Petersen RB et al.: Molecular assessment of the transmissibilities of BSE and scrapie to humans. Nature 1997, 388:285-288. The in vitro limited conversion of normal human protease-sensitive PrP (called PrPSEN by these authors) by the protease-resistant forms of PrP from scrapie and BSE into additional protease-resistant PrP (called PrPRES) suggests that both scrapie and BSE may not be readily transmissible to humans. It serves to highlight the effect of species barriers on transmission or host range control.
10. Zeidler M, Stewart G, Cousens SN, Estibeiro K, Will RG: Codon 129 genotype and new variant CJD. Lancet 1997, 350:668.
11. Buchanan CR, Preece MA, Milner RDG: Mortality, neoplasia and Creutzfeldt-Jacob disease in patients treated with pituitary growth hormone in the UK. Br Med J 1991, 302:824-828.
12. Yamada M, Itoh Y, Suematsu N, Matsushita M, Otomo E: Panencephalopathic type of Creutzfeldt-Jacob disease associated with cadaveric dura mater graft. J Neurol Neurosurg Psychiatry 1997, 63:524-527.
13. Heckmann JG, Lang CJG, Petruch F, Druschky A, Erb C, Brown P, Neundorfer B: Transmission of Creutzfeldt-Jacob disease via a corneal transplant. J Neurol Neurosurg Psychiatry 1997, 63:388-390.
14. Hill AF, Zeidler M, Ironside J, Collinge J: Diagnosis of new variant Creutzfeldt-Jacob disease by tonsil biopsy. Lancet 1997, 349:99-100.
15. Whittle IR, Will RG, Ironside JW: Brain biopsy and patients with atypical presentations of sporadic Creutzfeldt-Jacob disease. J Neurol Neurosurg Psychiatry 1997, 63:547-548.
16. res deposition. Clin Neuropath 1996, 15:358-360.
17. Calissano M, Petraroli R, Pocchiari M: Therapeutical approaches to transmissible spongiform encephalopathies (TSE): the case of Amphoteracin-B. J Biol Regul Homeost Agents 1996, 10:69-71.
18. 171), however, do exist in these countries. This supports the idea that natural scrapie has an infectious aetiology.
19. Hunter N, Goldmann W, Foster JD, Cairns D, Smith G: Natural scrapie and PrP genotype: case-control studies in British sheep. Vet Rec 1997, 141:137-140.
20. Sc in spleens of some scrapie-infected sheep but not BSE-infected cows. J Gen Virol 1997, 78:2389-2396.
21. Schreuder BEC, vanKeulen LJM, Vromans MEW, Langeveld JPM, Smits MA: Preclinical test for prion diseases. Nature 1996, 381:563.
22. Sc for decoration. Now the detection of transmissible spongiform encephalopathies should become more sensitive.
23. Lee KH, Harrington MG: 14-3-3 and BSE. Ver Rec 1997, 140:206-207.
24. Rosenmann H, Meiner Z, Kahana E, Halimi M, Lenetsky E, Abramsky O, Gabizon R: Detection of 14-3-3 protein in the CSF of genetic Creutzfeltd-Jacob disease. Neurology 1997, 49:593-595.
25. Otto M, Stein H, Szudra A, Zerr I, Bodemer M, Gefeller O, Poser S, Kretzschmar HA, Mader M, Weber T: S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jacob disease. J Neurol 1997, 244:566-570.
26. Tobler I, Deboer T, Fischer M: Sleep and sleep regulation in normal and prion protein-deficient mice. J Neurosci 1997, 17:1869-1879.
27. Sc using in vitro techniques. A possible explanation of scrapie as a 'protein only' disease is also presented.
28. Bessant RA, Raymond GJ, Caughey B: In situ formation of proteases-resistant prion protein in transmissible spongiform encephalopathy-infected brain slices. J Biol Chem 1997, 272:15227-15231.
29. Mihara H, Takahashi Y: Engineering peptides and proteins that undergo cc-to- β transitions. Curr Opin Struct Biol 1997, 7:501-508.
30. Glockshuber R, Hornemann S, Riek R, Wider G, Billeter M, Wuthrich K: Three-dimensional NMR structure of a self-folding domain of the prion protein PrP(121-231). Trends Biochem Sci 1997, 22:241-242. This study of PrP structure enables existing hypotheses on the conversion of the normal PrP protein into its transmissible spongiform encephalopathy isoform to be re-examined, as well as providing further possible insight into the species barrier at a molecular level.
31. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF: Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996, 383:685-690.
32. Somerville RA, Chong A, Mulqueen OU: Biochemical typing of scrapie strains. Nature 1997, 386:564. This study on PrP glycoform patterns in different strains of scrapie, including the BSE-derived 301V, shows that even strains from the same origin can have significant glycoform differences. This is exemplified by the strains 79A and 263K, which are at opposite ends of the glycoform spectrum and yet are both derived from the SSBP/1 isolate of scrapie. It is concluded that strains of transmissible spongiform encephalopathy with similar glycoform profiles may not necessarily have a common source.
33. DeArmond SJ, Yehiely F, Qiu Y, Ninchak-Casey A, Dagget V, Camerino AP, Caytano J, Rogers M, Groth D, Torchia M et al.: Selective neuronal targeting in prion disease. Neuron 1997, 19:1337-1348.
34. Billeter M, Riek R, Wider G, Hornemann S, Glockshuber R, Wuthrich K: Prion protein NMR structure and species barrier for prion diseases. Proc Natl Acad Sci USA 1997, 94:7281-7285.
35. Bruce M, Chree A, McConnell I, Foster J, Pearson G, Fraser H: Transmission of bovine spongiform encephalopathy and scarpie to mice: strain variation and the species barrier. Phil Trans R Soc Lond 1994, 343:405-411.
36. Moore RC, Hope J, McBride PA, McConnell I, Selfridge J, Melton DW, Manson JC: Mice with gene targetted prion protein alterations show that Prnp, Sinc and Prni are congruent Nat Genet 1998, 18:118-125. The major gene controlling mouse scrapie incubation is Sinc (also known as Prni), Gene targeting was used to construct mice in which the endogenous Prnp allele was modified to express PrPB instead of PrPA. PrPA and PrPB are PrP variants arising from codon 108L/F and 189T/V dimorphisms (where the letters represent in single-letter code the amino acids encoded by these codons). Incubation periods were markedly reduced when these mice were challenged with a mouse-passaged BSE strain, demonstrating that PrP dimorphisms at codons 108 and 189 control incubation time and that Sinc/Prni and Prnp are congruent.
37. Scott MR, Groth D, Tatzeit J, Torchia M, Tremblay P, DeArmond SJ, Prusiner SB: Propagation of prion strains through specific conformers of the prion protein. J Virol 1997, 71:9032-9044.
38. Sc from mouse PrPc because of a sequestering of the sites of conversion by the replacement residues and, it is argued, by the binding of protein X so that it was unavailable for prion propagation.
39. Farquhar CF, Somerville RA, Bruce ME: Straining the prion hypothesis. Nature 1998, 391:345-346.
40. Carp RI, Meeker H, Sersen E: Scrapie strains retain their distinctive characteristics following passages of homogenates from different brain regions and spleen. J Gen Virol 1997, 78:283-290.
41. +], a heritable prion-like factor of S. cerevisiae. Cell 1997, 89:811-819.
42. Weissmann C, Fischer M, Raeber A, Bueler H, Sailer A, Shmerling D, Rulicke T, Brandner S, Aguzzi A: The use of transgenic mice in the investigation of transmissible spongiform encephalopathies. Int J Exp Pathol 1996, 77:283-293.
43. Agguzzi A, Raeber A, Blattler T, Flechsig E, Klein M, Weissmann C, Brandner S: Neurotoxicity and neuroinvasiveness of prions. J Neurovirol 1997, 3:23-24.
44. Blattler T, Brandner S, Raeber AJ, Klein MA, Voigtlander T, Weissmann C, Aguzzi A: PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 1997, 389:69-73.
45. Brown KL, Stewart K, Bruce ME, Fraser H: Severely combined immunodeficient (SCID) mice resist infection with bovine spongiform encephalopathy. J Gen Virol 1997, 78:2707-2710.
46. 0/0), however, could be infected by the same route of challenge. The authors conclude that B cells are a limiting factor in the development of scrapie after peripheral inoculation and may be carriers of infectivity.
47. Ricketts MN, Cashman NR, Stratton EE, ElSaadany S: Is Creutzfeldt-Jacob disease transmitted in blood. Emerg Infect Dis 1997, 3:155-163.
48. 5-7. A route bypassing the spinal cord was detected through the dorsal vagus nerve which, emerges in the medulla of the brain and is part of the parasympathetic nervous system involved in innervation of the viscera.
49. O'Rourke KI, Holyoak GR, Clark WW, Mickelson JR, Wang S, Melco RP, Besser TE, Foote WC: PrP genotypes and experimental scrapie in orally inoculated Suffolk sheep in the United States. J Gen Virol 1997, 78:975-978.
50. Spraker TR, Miller MW, Williams ES, Getzy DM, Adrian WJ, Schoonveld GG, Spowart RA, O'Rourke KI, Miller JM, Merz PA: Spongiform encephalopathy in free-ranging mule deer (Odocoileus hemionus), white-tailed deer (Odocoileus virginianus) and rocky mountain elk (Cervus elaphus nelson) in northcentral Colorado. J Wild Dis 1997, 33:1-6.
51. Taylor DM, Woodgate SL: Bovine spongiform encephalopathy: the causal role of ruminant-derived protein in cattle diets. Revue Scientifique et Technique-Office International des Epizooties 1997, 16:187-198.
52. Foster JD, Bruce M, McConnell I, Chree A, Fraser H: Detection of BSE infectivity in brain and spleen of experimentally infected sheep. Vet Rec 1996, 138:546-548.